If Ozempic Makes People Eat Less, Maker of Cheez-It Will Be Ready

Weight-Loss Drugmaker Carmot Therapeutics Is Considering IPO

Weight-Loss Drugs Pose Risks for People Over 65, Experts Say

Europe Luxury Stocks Slide as Richemont Chairman Says Inflation Is Denting Demand

Novo’s Obesity Drug Arrives in UK – at a Fraction of US Prices

Ozempic Maker Overtakes LVMH as Biggest European Company

Ozempic Could Be The Next Target of Medicare Price Negotiations

Weight-Loss Drugs Cost Far More in US Than Other Nations

Slimfast Fades as Dieters Turn to Weight Loss Drugs

European Stocks Lifted by Luxury as China Eases Travel Curbs

Novo’s Blockbuster Obesity Drug Still Hit by US Bottlenecks

Novo’s Value Surpasses Denmark GDP After Obesity Drug Boost